Search Login Register

pirarubicin Summary

Also Known As: 4'-O-tetrahydropyranyladriamycin; 4'-O-tetrahydropyranyldoxorubicin; 4'-O-tetrapyranyldoxorubicin; Aventis brand of pirarubicin; THP-ADM Show All >>

Networked: 383 relevant articles (45 outcomes, 83 trials/studies) for this Bio-Agent

Key Diseases for which pirarubicin is Relevant

  1. Neoplasms (Cancer) : 7 outcomes 14 studies in 100 results
  2. Breast Neoplasms (Breast Cancer) : 5 outcomes 12 studies in 35 results
  3. Urinary Bladder Neoplasms (Bladder Cancer) : 4 outcomes 16 studies in 52 results
  4. Carcinoma (Carcinomatosis) : 4 outcomes 10 studies in 29 results
  5. Osteosarcoma (Osteogenic Sarcoma) : 4 outcomes 4 studies in 11 results
Show All >>

Drugs Related to pirarubicin

  1. Doxorubicin (Adriamycin)
  2. Vincristine (Oncovin)
  3. Cyclophosphamide (Cytoxan)
  4. Prednisolone (Predate)
  5. Cisplatin (Platino)
  6. pirarubicin
  7. Fluorouracil (Carac)
  8. Epirubicin (Ellence)
  9. docetaxel (Taxotere)
  10. Etoposide (VP 16)
Show All >>

Therapies Related to pirarubicin

  1. Drug Therapy (Chemotherapy)
  2. Intravesical Administration
  3. Combination Drug Therapy (Combination Chemotherapy)
  4. Radiotherapy
  5. Adjuvant Chemotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.